RxDoctor Payments Data

Ashlee Schaa

Family · Cincinnati, OHNPI 1063062966

Payments from drug & device makers

$443in general payments, 2019–2025

Across 28 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$130
  • Novo Nordisk$87
  • Lilly USA, LLC$64
  • Avanir Pharmaceuticals, Inc.$25
  • Actelion Pharmaceuticals US, Inc.$25
  • Edwards Lifesciences$22
  • plus $89 from 6 others

What the payments were for

  • Food & beverage$443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$443 in reported general payments places this provider in the 55th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$50,205
Medicare patients
322
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$37,767
JardianceEmpagliflozin29$36,697
TrulicityDulaglutide13$30,700
OzempicSemaglutide15$18,391
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$17,201
JanuviaSitagliptin Phosphate13$13,991
Lantus SolostarInsulin Glargine,hum.Rec.Anlog49$7,207
NovologInsulin Aspart12$2,413
Levothyroxine Sodium179$1,784
Atorvastatin Calcium240$1,684
Nano 2nd Gen Pen NeedlePen Needle, Diabetic17$1,628
Rosuvastatin Calcium174$1,573
Albuterol Sulfate HfaAlbuterol Sulfate54$1,403
Omeprazole126$1,354
Pantoprazole Sodium110$1,302

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$12$36,69729 claims
Lilly USA, LLCTrulicity$64$30,70013 claims
Novo NordiskOzempic, Novolog$87$20,80327 claims
GSKTrelegy Ellipta$15$17,20121 claims
AbbVieSynthroid$130$1,06116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 6,812 family providers in Ohio.

Other family in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →